Peter Allen, BA ACA - Non-Executive Chairman
Peter Allen is non-executive Chairman of the Board of Directors of Diurnal and joined the Group in July 2015. Peter has over 20 years’ experience in senior board positions in a wide portfolio of healthcare companies. He is currently non-executive Chairman of AIM-quoted Advanced Medical Solutions plc, main market-quoted Future plc, AIM-quoted Clinigen plc, as well as privately owned Oxford Nanopore Technologies Ltd. Previously, Peter was Chairman and interim Chief Executive Officer of ProStrakan Group Plc and spent three years as Chairman of Proximagen Neuroscience Plc (now Proximagen Group Limited). Prior to this, he was Chief Financial Officer of Celltech Group plc between 1992 and 2004. In addition to managing Celltech’s flotation process in 1993, Peter played a key role in several strategic acquisitions, including Chiroscience Group plc, Medeva plc and Oxford Glycosciences plc. In 2003, Peter was also appointed Deputy Chief Executive Officer of Celltech until the Company was sold to UCB in 2004. Peter is a qualified chartered accountant by background and has a joint degree in Accountancy and Law.